Novel Anti-rnf43 antibodies and methods of use

MA39896AUndetermined Publication Date: 2017-03-01ABBVIE STEMCENTRX LLC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39896
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-04-21
Filing Date: 2015-04-21
Publication Date: 2017-03-01

Application Information

Patent Timeline

21 Apr 2014

Priority

21 Apr 2015

Application

MA39896

01 Mar 2017

Publication

MA39896A

IPC: C07K16/46; A61K39/395

CPC: C07K16/28; C07K16/30; C07K2317/24; C07K2317/56; C07K2317/76; C07K2317/92; A61K47/6857; A61K47/6863

Inventors: AUJAY Monette; BOONTANRART Mandy

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention discloses novel anti-rnf43 antibodies and derivatives thereof, including antibody drug conjugates, and methods of using such anti-rnf43 antibodies and antibody drug conjugates to diagnose and treat cancer.

Need to check novelty before this filing date? Find Prior Art